Production (Stage)
Biocure Technology Inc.
BICTF
$0.01
$0.0086614.29%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -70.32% | 55.99% | 60.94% | 59.50% | 52.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -70.32% | 55.99% | 60.94% | 59.50% | 52.33% |
| Operating Income | 70.32% | -55.99% | -60.94% | -59.50% | -52.33% |
| Income Before Tax | 82.45% | -263.78% | -268.24% | -259.39% | -244.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 82.45% | -263.78% | -268.24% | -259.39% | -244.11% |
| Earnings from Discontinued Operations | -- | 95.70% | 96.53% | 91.23% | 69.62% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -91.86% | -94.70% | -79.48% | -59.76% |
| Net Income | 85.61% | -346.70% | -385.29% | -0.27% | -18.52% |
| EBIT | 70.32% | -55.99% | -60.94% | -59.50% | -52.33% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 86.00% | -337.52% | -379.32% | -19.13% | -36.06% |
| Normalized Basic EPS | 75.33% | -96.08% | -74.57% | -96.02% | -91.56% |
| EPS Diluted | 86.00% | -337.52% | -379.32% | -19.13% | -36.06% |
| Normalized Diluted EPS | 75.33% | -96.08% | -74.57% | -96.02% | -91.56% |
| Average Basic Shares Outstanding | -10.39% | -11.49% | 156.31% | 156.57% | 161.70% |
| Average Diluted Shares Outstanding | -10.39% | -11.49% | 156.31% | 156.57% | 161.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |